Glycogen storage disease type V

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Glycogen storage disease type V | |
|---|---|
| Synonyms | McArdle's disease, Myophosphorylase deficiency |
| Pronounce | |
| Specialty | Neurology, Genetics |
| Symptoms | Muscle pain, cramps, exercise intolerance, myoglobinuria |
| Complications | N/A |
| Onset | Childhood or early adulthood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the PYGM gene |
| Risks | Family history of the condition |
| Diagnosis | Genetic testing, muscle biopsy, blood test |
| Differential diagnosis | Other glycogen storage diseases, muscle disorders |
| Prevention | N/A |
| Treatment | Dietary management, exercise therapy |
| Medication | |
| Prognosis | Generally good with management |
| Frequency | Rare |
| Deaths | |
Glycogen Storage Disease Type V (also known as McArdle's Disease) is a rare genetic disorder characterized by a deficiency in the enzyme myophosphorylase. This enzyme is necessary for the breakdown of glycogen in muscle cells. The lack of this enzyme leads to symptoms such as muscle weakness and cramps.
Symptoms[edit]
The symptoms of Glycogen Storage Disease Type V typically begin in childhood or adolescence. They include:
- Muscle weakness
- Muscle cramps
- Exercise intolerance
- Fatigue
- Myoglobinuria (presence of myoglobin in urine)
Causes[edit]
Glycogen Storage Disease Type V is caused by mutations in the PYGM gene. This gene provides instructions for making the enzyme myophosphorylase, which is necessary for the breakdown of glycogen in muscle cells. When mutations occur in the PYGM gene, the enzyme's activity is reduced or eliminated, preventing the breakdown of glycogen and leading to the symptoms of the disease.
Diagnosis[edit]
Diagnosis of Glycogen Storage Disease Type V is typically made through a combination of clinical examination, laboratory testing, and genetic testing. The Forearm ischemic exercise test is a common diagnostic tool used to identify the disease.
Treatment[edit]
There is currently no cure for Glycogen Storage Disease Type V. Treatment is focused on managing symptoms and includes:
See also[edit]
References[edit]
<references />
External links[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian